- Investing Ideas
- Australian Pharmaceuticals & Biotech Pure Equity Growth
Australian Pharmaceuticals & Biotech Pure Equity Growth
Results
2
0 new
Companies that has zero debt on their balance sheet and is forecast to grow at an exponential rate in the future.
2 companies
Neuren Pharmaceuticals
Market Cap: AU$2.4b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$21.64
7D
26.3%
1Y
27.2%
Neuren Pharmaceuticals
Market Cap: AU$2.4b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$18.70
7D
9.1%
1Y
10.4%